Pfizer Posts Positive Late-Stage Results in Colitis Trials
Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in ulcerative colitis program at the 11th Congress of European Crohn's and Colitis…